MedTech Acquisition Corp - Ordinary Shares - Class A

NASDAQ:MTAC   3:59:53 PM EDT
9.90
-0.03 (-0.30%)
Equity Financing / Related, Initial Public Offerings

Memic Innovative Surgery Ltd. And Medtech Acquisition Corporation Announce Proposed Business Combination

Published: 08/13/2021 15:28 GMT
MedTech Acquisition Corp - Ordinary Shares - Class A (MTAC) - Memic Innovative Surgery Ltd.
and Medtech Acquisition Corporation Announce Proposed Business Combination.
Medtech Acquisition - Combined Cos Valued at Estimated Pro-forma Equity Value of More Than $1 Billion, Assuming No Redemptions by Co's Public Stockholders.
Medtech Acquisition - Business Combination Supported by $76 Million Pipe With Participation From Investors Including Bridger Healthcare, the Kraft Group, Others.
Medtech Acquisition Corp - Upon Closing of Transaction, Combined Co Will Operate Under the Memic Name.
Medtech Acquisition Corp - Upon Closing of Transaction, Maurice R. FerrÉ, Will Become Executive Chairman of Combined Co.
Medtech Acquisition Corp - Memic Will Apply to Have Ordinary Shares Listed on Nasdaq Stock Market.
Medtech Acquisition - Following Completion of Transaction & Pipe, Security Holders of Memic Are Expected to Own About 61.6% of Combined Co.
Medtech Acquisition - Following Completion of Transaction & Pipe, Medtech Stockholders Expected to Own 24.7%, Pipe Investors 7.5% of Combined Co.
Further Company Coverage: Mtaco ((reuters.
Briefs@thomsonreuters.
Com;)).